{
  "meta": {
    "title": "Mid_Day_Module_Medicine-8",
    "url": "https://brainandscalpel.vercel.app/mid-day-module-medicine-8-79504343.html",
    "scrapedAt": "2025-11-29T18:15:15.581Z"
  },
  "questions": [
    {
      "id": 92169,
      "choices": [
        {
          "id": 366992,
          "text": "<p><span style=\"font-size:14.0pt;\">Congo red</span></p>"
        },
        {
          "id": 366993,
          "text": "<p><span style=\"font-size:14.0pt;\">Periodic Acid-Schiff</span></p>"
        },
        {
          "id": 366994,
          "text": "<p><span style=\"font-size:14.0pt;\">Gomori Methenamine Silver</span></p>"
        },
        {
          "id": 366995,
          "text": "<p><span style=\"font-size:14.0pt;\">Fontana-Masson</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A post-renal transplant patient presents with fever and breathlessness. Lung biopsy is done. Which of the following stains is least useful in identifying the causative organism? (INICET MAY 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Zxson4G.png\" width=\"621\" height=\"448\"></span></p>",
      "unique_key": "Q6374679",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731728,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Congo red</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Congo red stain is least useful in identifying the causative organism in this post-transplant patient with pneumonia.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Congo red is specifically used to detect amyloid deposits, which show characteristic apple-green birefringence under polarized light. It is not used for identifying infectious organisms.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the context of a post-renal transplant patient presenting with fever and breathlessness, the most likely diagnosis is Pneumocystis jirovecii pneumonia (PCP), which is a common opportunistic infection in immunocompromised patients. The lung biopsy shows cysts typical of Pneumocystis, which would not be detected by Congo red staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Periodic Acid-Schiff (PAS):</strong> This is a very useful stain for identifying Pneumocystis jirovecii. PAS stain is excellent for detecting the cyst wall of Pneumocystis organisms and is one of the standard stains used for diagnosing PCP in immunocompromised patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gomori Methenamine Silver (GMS):</strong> This is considered the gold standard for staining fungal elements, including Pneumocystis jirovecii. GMS stain clearly demonstrates the characteristic cyst forms of Pneumocystis and is the most commonly used stain for diagnosing PCP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Fontana-Masson:</strong> This stain can be useful for identifying certain organisms, particularly those that are argentophilic (silver-loving). While not specifically for Pneumocystis, it can be used to stain organisms like Cryptococcus and has some utility in identifying certain infectious agents, making it more useful than Congo red in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Congo red stain is used specifically for detecting amyloid deposits and is not useful for identifying infectious organisms in post-transplant opportunistic infections.</span></p>",
      "correct_choice_id": 366992,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92169/INI_CET_May_2025_Medicine_Q_-_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92169/INI_CET_May_2025_Medicine_Q_-_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92170,
      "choices": [
        {
          "id": 366996,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudomembranous enterocolitis</span></p>"
        },
        {
          "id": 366997,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulcerative colitis</span></p>"
        },
        {
          "id": 366998,
          "text": "<p><span style=\"font-size:14.0pt;\">Crohn's disease</span></p>"
        },
        {
          "id": 366999,
          "text": "<p><span style=\"font-size:14.0pt;\">Intestinal TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old man presents with an 8-month history of chronic diarrhea. Barium investigation shows loss of haustrations. Based on these findings, what is the diagnosis? (INICET MAY 2025)</span></p>",
      "unique_key": "Q3238464",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ulcerative colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The combination of 8-month history of chronic diarrhea and loss of haustrations on barium study is characteristic of ulcerative colitis. Loss of haustrations creates the classic <strong>\"lead pipe\" appearance</strong> of the colon on barium enema, which is pathognomonic for ulcerative colitis.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This finding indicates chronic inflammation that has led to loss of the normal colonic haustral folds. Ulcerative colitis typically presents with chronic bloody diarrhea and involves the colon in a continuous pattern starting from the rectum. The 8-month duration is consistent with the chronic nature of inflammatory bowel disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pseudomembranous enterocolitis:</strong> This condition is caused by Clostridium difficile and requires a history of antibiotic exposure. It typically presents acutely rather than with an 8-month chronic history. The patient would need recent antibiotic use to develop C. difficile-associated disease, and the chronic nature of symptoms makes this diagnosis unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Crohn's disease:</strong> While Crohn's disease can involve the colon, it most commonly affects the terminal ileum and demonstrates skip lesions rather than continuous involvement. Pure colonic involvement with loss of haustrations is more characteristic of ulcerative colitis. Crohn's disease typically shows a <strong>\"garden hose\" appearance</strong> rather than the \"lead pipe\" sign.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intestinal TB:</strong> This condition predominantly affects the terminal ileum and ileocecal region, similar to Crohn's disease. It rarely causes the characteristic loss of haustrations seen throughout the colon that is typical of ulcerative colitis. Intestinal TB would not typically present with this specific radiological finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Loss of haustrations on barium study creating a \"lead pipe\" appearance is pathognomonic for ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>IBD -&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_524C8eA.png\" width=\"1207\" height=\"774\"></strong></span></p>",
      "correct_choice_id": 366997,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92170/INI_CET_May_2025_Medicine_Q_-_26.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92170/INI_CET_May_2025_Medicine_Q_-_26.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74900,
      "choices": [
        {
          "id": 298497,
          "text": "<p><span style=\"font-size:16px;\">A, B</span></p>"
        },
        {
          "id": 298498,
          "text": "<p><span style=\"font-size:16px;\">A only</span></p>"
        },
        {
          "id": 298499,
          "text": "<p><span style=\"font-size:16px;\">A, B and C</span></p>"
        },
        {
          "id": 298500,
          "text": "<p><span style=\"font-size:16px;\">A, B, D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following findings are typically associated with glomerular hematuria? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:16px;\">Brown urine</span></li><li><span style=\"font-size:16px;\">Dysuria absent</span></li><li><span style=\"font-size:16px;\">Crystals in urine</span></li><li><span style=\"font-size:16px;\">Edema is rare</span></li></ol>",
      "unique_key": "Q8668544",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) A, B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glomerular hematuria has specific characteristics that help differentiate it from non-glomerular causes:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>A.&nbsp;Brown urine:</strong> Brown/cola-colored urine is typical of glomerular hematuria due to the presence of RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>B.&nbsp;Dysuria absent:</strong> Absence of dysuria is characteristic, as there is no urinary tract inflammation or infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These findings together strongly suggest glomerular origin of hematuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>C. Crystals in urine:&nbsp;</strong>Incorrect. Crystalluria is not a feature of glomerular hematuria. Instead, findings like dysmorphic RBCs, acanthocytes, or RBC casts are characteristic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>D. Edema is rare:</strong> Incorrect. Edema is common in glomerular diseases, whether nephritic or nephrotic, due to:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Loss of albumin leading to decreased oncotic pressure</span></li><li><span style=\"font-size:16px;\">Activation of the renin-angiotensin system</span></li><li><span style=\"font-size:16px;\">Underlying inflammatory processes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glomerular hematuria includes brown/cola-colored urine and absence of dysuria, while presence of edema and absence of urinary crystals are other important characteristics.</span></p>",
      "correct_choice_id": 298497,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74900/INI-CET_NOV_2024_Medicine_Q_-_25.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74900/INI-CET_NOV_2024_Medicine_Q_-_25.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74901,
      "choices": [
        {
          "id": 298501,
          "text": "<p><span style=\"font-size:16px;\">Medullary thyroid carcinoma</span></p>"
        },
        {
          "id": 298502,
          "text": "<p><span style=\"font-size:16px;\">Mucosal ganglioneuromatosis</span></p>"
        },
        {
          "id": 298503,
          "text": "<p><span style=\"font-size:16px;\">Parathyroid hyperplasia</span></p>"
        },
        {
          "id": 298504,
          "text": "<p><span style=\"font-size:16px;\">Marfanoid habitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Features of MEN2B are all except: (INICET NOV 2024)</span></p>",
      "unique_key": "Q8100054",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Parathyroid hyperplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">MEN2B syndrome is characterized by a distinct set of clinical features known as the \"4 M's\":</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Marfanoid body habitus</span></li><li><span style=\"font-size:16px;\">Mucosal neuromas</span></li><li><span style=\"font-size:16px;\">Medullary thyroid carcinoma (MTC)</span></li><li><span style=\"font-size:16px;\">Megacolon (Hirschsprung disease)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Additionally, pheochromocytoma is also a feature of MEN2B. The syndrome is caused by mutations in the RET proto-oncogene located on chromosome 10.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Parathyroid hyperplasia is NOT a component of MEN2B syndrome, while the characteristic features include medullary thyroid carcinoma, mucosal neuromas, marfanoid habitus, and megacolon (the 4 M's).</span></p>",
      "correct_choice_id": 298503,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74901/INI-CET_NOV_2024_Medicine_Q_-_26.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74901/INI-CET_NOV_2024_Medicine_Q_-_26.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59286,
      "choices": [
        {
          "id": 236457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vanishing testis syndrome</span></span></p>"
        },
        {
          "id": 236458,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Klinefelter&#39;s syndrome</span></span></p>"
        },
        {
          "id": 236459,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noonan syndrome</span></span></p>"
        },
        {
          "id": 236460,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal hyperplasia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A tall male presents with absent pubic and axillary hair, infantile genitalia, high LH and FSH levels with XXY karyotype. What is the most probable diagnosis? (FMGE JUNE 2022)</span></span></p>",
      "unique_key": "Q2200685",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731732,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Klinefelter&#39;s syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Klinefelter&#39;s syndrome is characterized by the presence of an extra X chromosome (47,XXY karyotype). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients present with hypogonadism (testicular atrophy), reduced secondary sexual characteristic, often grow taller and have more body hair, but without male pattern baldness. They may also develop gynecomastia due to an imbalance of testosterone and estrogen. Due to insufficient testosterone production, LH and FSH levels are elevated, resulting in hypergonadotropic hypogonadism. The high LH and FSH levels are a consequence of low testosterone feedback.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Vanishing testis syndrome:</span></strong><span style=\"font-size:12.0pt\"> Typically presents with normal male karyotype (46,XY).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Noonan syndrome:</span></strong><span style=\"font-size:12.0pt\"> Presents with features similar to Turner syndrome but normal male karyotype.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Adrenal hyperplasia:</span></strong><span style=\"font-size:12.0pt\"> Presents with ambiguous genitalia and other features but not associated with XXY karyotype.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong><span style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Klinefelter&#39;s syndrome is characterized by tall stature, hypogonadism, and 47,XXY karyotype.</span></span></span></p>",
      "correct_choice_id": 236458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47524,
      "choices": [
        {
          "id": 189707,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></span></span></p>"
        },
        {
          "id": 189708,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG</span></span></span></span></p>"
        },
        {
          "id": 189709,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></span></span></p>"
        },
        {
          "id": 189710,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgE</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following autoantibody isotypes is involved in the pathogenesis of Acute Inflammatory Demyelinating Polyneuropathy (AIDP)? (</span></span>FMGE July 2023)</p>",
      "unique_key": "Q3800603",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731733,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) IgG</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is the most common form of Guillain-Barr&eacute; Syndrome (GBS). The pathogenesis of AIDP involves autoimmune mechanisms where the body&#39;s immune system mistakenly attacks the peripheral nerves. This autoimmune response primarily involves the production of <strong>IgG antibodies</strong> against gangliosides present on the nerve membranes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG antibodies are significant in the diagnosis and monitoring of Guillain-Barr&eacute; Syndrome, and tests for ganglioside antibodies (such as anti-GM1 IgG) are commonly ordered in clinical settings to support the diagnosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IgA:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA is primarily involved in mucosal immunity and is not a key player in the pathogenesis of AIDP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IgM:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although IgM antibodies are involved in initial immune responses, they are not primarily associated with AIDP pathogenesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. IgE:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgE is associated with allergic reactions and parasitic infections, not with the autoimmune processes seen in AIDP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objectives</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG antibodies are involved in the pathogenesis of Acute Inflammatory Demyelinating Polyneuropathy (AIDP), which is the most common form of Guillain-Barr&eacute; Syndrome.</span></span></span></span></p>",
      "correct_choice_id": 189708,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47527,
      "choices": [
        {
          "id": 189719,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac failure</span></p>"
        },
        {
          "id": 189720,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal failure</span></p>"
        },
        {
          "id": 189721,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain injury</span></p>"
        },
        {
          "id": 189722,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old man presents to the OPD with bilateral swelling of lower limbs. On examination, there is elevated JVP, hepatomegaly, and ascites. What is your provisional diagnosis? (</span>FMGE July 2023)</p>",
      "unique_key": "Q1908431",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731734,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cardiac failure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms and signs that are consistent with cardiac failure (congestive heart failure):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Bilateral swelling of lower limbs:&nbsp;</strong>Suggestive of peripheral edema, common in heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated JVP (Jugular Venous Pressure):&nbsp;</strong>Indicates increased central venous pressure, often seen in right-sided heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatomegaly:&nbsp;</strong>Enlargement of the liver due to congestion, often a sign of right-sided heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ascites:&nbsp;</strong>Accumulation of fluid in the peritoneal cavity, which can occur in both cardiac and hepatic failure but is more indicative of cardiac failure in the absence of jaundice or other liver failure signs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Renal failure:&nbsp;</strong>Can cause peripheral edema but does not typically present with elevated JVP, hepatomegaly, and ascites in this manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Brain injury:&nbsp;</strong>Does not present with these systemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hepatic failure:&nbsp;</strong>While it can cause ascites and hepatomegaly, it would also present with jaundice and other liver-related symptoms, which are not mentioned in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardiac failure (congestive heart failure) often presents with elevated JVP, peripheral edema, hepatomegaly, and ascites, distinguishing it from other conditions like hepatic or renal failure.</span></p>",
      "correct_choice_id": 189719,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48173,
      "choices": [
        {
          "id": 192287,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial Effusion</span></p>"
        },
        {
          "id": 192288,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive Pericarditis</span></p>"
        },
        {
          "id": 192289,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
        },
        {
          "id": 192290,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Auenbruggerâ€™s sign is seen in: (NEET PG 2017)</span></p>",
      "unique_key": "Q9232751",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731735,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Pericardial Effusion</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Auenbrugger's sign refers to dullness in the left posterior lung field (at the base) that is seen in patients with large pericardial effusions. This is also known as <strong>Ewart's sign</strong>. When the pericardium expands due to fluid accumulation, it causes minicollapse and dullness in the left posterior lung field, which can be detected on percussion examination. This physical finding is characteristic of significant pericardial effusions.</p><p>&nbsp;</p><p><strong>&nbsp;Other Options:&nbsp;</strong></p><p>&nbsp;</p><p><strong>Option B. Constrictive Pericarditis</strong>: Constrictive pericarditis presents with signs of right heart failure, increased JVP with prominent x and y descent, pericardial knock, and Kussmaul's sign (no respiratory variation of JVP). Auenbrugger's sign is not a feature of constrictive pericarditis.</p><p>&nbsp;</p><p><strong>Option C. Aortic Regurgitation</strong>: Aortic regurgitation typically presents with wide pulse pressure, diastolic murmur, and signs of left ventricular volume overload. Auenbrugger's sign is not associated with this valvular condition.</p><p>&nbsp;</p><p><strong>Option D. Mitral Stenosis</strong>: Mitral stenosis typically presents with symptoms of pulmonary congestion, a diastolic murmur, and possible atrial fibrillation. Auenbrugger's sign is not a feature of mitral stenosis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Auenbrugger's sign (also known as Ewart's sign) is a physical finding characterized by dullness in the left posterior lung field due to compression by an enlarged pericardium in patients with large pericardial effusions.</span></p>",
      "correct_choice_id": 192287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16176,
      "choices": [
        {
          "id": 64664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constrictive pericarditis</span></span></span></p>"
        },
        {
          "id": 64665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aortic regurgitation</span></span></span></p>"
        },
        {
          "id": 64666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tricuspid stenosis</span></span></span></p>"
        },
        {
          "id": 64667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary arterial hypertension</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient presents with dyspnea and distended neck veins that increase on inspiration. There is no murmur. What is the diagnosis? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q9155427",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Constrictive pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The key clinical feature in this scenario is <strong>Kussmaul&#39;s sign,</strong> which is the paradoxical increase in jugular venous pressure (JVP) during inspiration. This is indicative of conditions that impede the normal inspiratory decrease in JVP, such as constrictive pericarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Features of Constrictive Pericarditis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kussmaul&#39;s Sign:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Lack of normal inspiratory decrease in JVP, or paradoxical increase, due to rigid pericardium that limits cardiac filling.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dyspnea:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Common due to impaired filling of the heart.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absence of Murmur:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Distinguishes it from valvular heart diseases.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Aortic regurgitation:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Aortic regurgitation typically presents with a diastolic murmur and does not cause Kussmaul&#39;s sign.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Tricuspid stenosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Tricuspid stenosis can cause elevated JVP, but it is usually associated with a diastolic murmur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Pulmonary arterial hypertension:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pulmonary arterial hypertension can cause elevated JVP, but it is not typically associated with Kussmaul&#39;s sign.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kussmaul&#39;s sign, an increase in JVP on inspiration, is indicative of constrictive pericarditis. It is not associated with murmurs or primary valvular heart diseases.</span></span></span></p>",
      "correct_choice_id": 64664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16177,
      "choices": [
        {
          "id": 64668,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyaline membrane disease</span></span></span></p>"
        },
        {
          "id": 64669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystic fibrosis</span></span></span></p>"
        },
        {
          "id": 64670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha 1 anti-trypsin deficiency</span></span></span></p>"
        },
        {
          "id": 64671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malabsorption syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 5-year-old child presented with recurrent respiratory infections with thickened sputum. CXR showed bronchial wall thickening. He has been suffering from steatorrhea since birth. Which of the following is the first differential diagnosis? (FMGE JAN 2023)</span></span></span></p>",
      "unique_key": "Q1147475",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731737,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Cystic fibrosis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cystic </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">fibrosis (CF) is a genetic disorder that leads to thick, sticky mucus production, affecting the lungs and digestive system. The key features in this case are recurrent respiratory infections, thickened sputum, bronchial wall thickening seen on CXR, and steatorrhea since birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Features of Cystic Fibrosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Recurrent Respiratory Infections:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Due to thick mucus obstructing airways and predisposing to infections.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thickened Sputum:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A hallmark of CF due to mucus gland dysfunction.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bronchial Wall Thickening:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Visible on CXR, indicative of chronic respiratory disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Steatorrhea:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Due to pancreatic insufficiency leading to fat malabsorption.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Hyaline membrane disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This typically presents in neonates with respiratory distress syndrome, not in a 5-year-old with chronic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Alpha 1 anti-trypsin deficiency:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition can cause emphysema and liver disease, but it does not typically present with steatorrhea or bronchiectasis in early childhood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Malabsorption syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While this explains steatorrhea, it does not account for the respiratory symptoms and bronchiectasis seen in CF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystic fibrosis should be the first differential diagnosis in children with recurrent respiratory infections, thickened sputum, bronchial wall thickening on CXR, and steatorrhea since birth.</span></span></span></p>",
      "correct_choice_id": 64669,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16310,
      "choices": [
        {
          "id": 65200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute lymphoblastic leukemia (ALL)</span></span></span></p>"
        },
        {
          "id": 65201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute myeloblastic leukemia (AML)</span></span></span></p>"
        },
        {
          "id": 65202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preleukemia</span></span></span></p>"
        },
        {
          "id": 65203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aleukemic leukemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 50-year-old man presents to you with features of anemia, fever, and recurrent nose bleeds. On examination there is hepatosplenomegaly, Lab investigations revealed: Hb = 6g/dL, TLC count = 40,000/ cu.mm with 10% blasts and platelet count = 12,000/cu.mm. On further investigation, t(8;21) was detected in the blasts. What is the diagnosis? (FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q6789448",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731738,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Acute myeloblastic leukemia (AML)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of anemia, hepatosplenomegaly, blasts in the blood (&lt;20%), and the <strong>t(8;21) </strong>translocation is indicative of AML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Typically, the diagnosis of AML requires a blast count greater than 20; However, if a signature cytogenetic abnormality, such as t(8,21), is present, a diagnosis of AML can be made even if the blast count is less than 20%.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other key cytogenetic changes indicative of AML include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">t(15;17)</span></strong><span style=\"font-size:12.0pt\">: This translocation results in the PML-RARA fusion protein.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Inversion 16 (or t(16;16))</span></strong><span style=\"font-size:12.0pt\">: Known as inversion 16 or CBF (core binding factor) leukemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">These 3 signature cytogenetic abnormalities are so characteristic of AML </span></strong><span style=\"font-size:12.0pt\">that their presence alone can confirm the diagnosis, bypassing the need for a high blast count.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Acute lymphoblastic leukemia (ALL):</span></strong><span style=\"font-size:12.0pt\"> Typically presents in children and does not commonly show t(8;21).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Preleukemia:</span></strong><span style=\"font-size:12.0pt\"> Not a definitive diagnosis with these findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aleukemic leukemia:</span></strong><span style=\"font-size:12.0pt\"> Refers to leukemia without blasts in the peripheral blood, which is not the case here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AML is suggested by anemia, hepatosplenomegaly, blasts in blood, and the t(8;21) translocation.</span></span></span></p>",
      "correct_choice_id": 65201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16311,
      "choices": [
        {
          "id": 65204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dubin-Johnson syndrome</span></span></span></p>"
        },
        {
          "id": 65205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Criggler-Najar type 1 syndrome</span></span></span></p>"
        },
        {
          "id": 65206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome</span></span></span></p>"
        },
        {
          "id": 65207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rotor Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 20-year-old male presented with a 1-week history of yellow skin and sclerae but is otherwise asymptomatic. He gives a history of viral infection for 10 days which resolved 2 days back. There is a history of a similar episode of icterus 2 years back for a period of 2 weeks. The current serum bilirubin is 2.4 mg/ dL, unconjugated bilirubin 2.1mg/dl, conjugated bilirubin is 0.3mg/dl, Serum AST and ALT levels are normal. What is the likely diagnosis? (FMGE DEC 2021)</span></span></span></p>",
      "unique_key": "Q8908563",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731739,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Gilbert syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome is characterized by intermittent jaundice with elevated unconjugated bilirubin levels and normal liver enzyme levels, often triggered by stress or illness. The patient&rsquo;s history of similar episodes and current lab findings fit the profile of Gilbert syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome is a benign condition characterized by mild elevations in unconjugated bilirubin, often occurring during periods of stress such as dehydration, fasting, surgery, or viral illness. Patients are typically asymptomatic, and the bilirubin elevation is usually transient and accompanied by normal liver enzymes and imaging. Viral markers are negative, and the condition is often discovered incidentally. The bilirubin levels do not exceed 3 milligrams per deciliter. Gilbert syndrome requires no treatment and is a common, harmless condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dubin-Johnson syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Typically shows <strong>conjugated</strong> hyperbilirubinemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Criggler-Najar type 1 syndrome:</span></strong><span style=\"font-size:12.0pt\"> Severe form with persistent high unconjugated bilirubin levels from birth. the enzyme UDP-glucuronosyltransferase (UGT1A1) activity is essentially zero. This complete lack of enzyme activity leads to severe jaundice from birth. Liver transplantation is often necessary for survival, as the condition is fatal if untreated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rotor Syndrome:</span></strong><span style=\"font-size:12.0pt\"> Similar to Dubin-Johnson but without liver pigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gilbert syndrome causes intermittent jaundice with unconjugated hyperbilirubinemia and normal liver enzymes.</span></span></span></p>",
      "correct_choice_id": 65206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59450,
      "choices": [
        {
          "id": 237113,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyproheptadine</span></p>"
        },
        {
          "id": 237114,
          "text": "<p><span style=\"font-size:12.0pt;\">Flumazenil</span></p>"
        },
        {
          "id": 237115,
          "text": "<p><span style=\"font-size:12.0pt;\">L-carnitine</span></p>"
        },
        {
          "id": 237116,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucovorin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with a history of depression was initially being treated with amitriptyline, but his symptoms were not adequately controlled. His medication regimen was changed to include an MAO inhibitor and sertraline. Shortly after this, he developed agitation and seizures. On examination, he had marked hyperreflexia and tremors. Which of the following is the most appropriate treatment? (NEET PG 2024)</span></p>",
      "unique_key": "Q4589341",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cyproheptadine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is presenting with symptoms of serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin levels in the brain. This is likely due to the combination of an MAO inhibitor and sertraline, both of which can increase serotonin levels. Cyproheptadine is a serotonin antagonist that can help block the effects of excessive serotonin, making it the most appropriate treatment in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Flumazenil:</strong> Flumazenil is a benzodiazepine antagonist used to reverse the effects of benzodiazepine overdose. It is not indicated in serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. L-carnitine:</strong> L-carnitine is an amino acid derivative that plays a role in energy metabolism. It has no role in the treatment of serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leucovorin:</strong> Leucovorin is a form of folic acid used to reduce the toxicity of certain chemotherapy drugs. It has no role in the treatment of serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Combining MAO inhibitors and serotonergic medications like sertraline can lead to serotonin syndrome, a potentially life-threatening condition. Cyproheptadine is the drug of choice for treating serotonin syndrome.</span></p>",
      "correct_choice_id": 237113,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59450/Neet_Pg_Aug_2024_Medicine_Q_35.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59450/Neet_Pg_Aug_2024_Medicine_Q_35.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59451,
      "choices": [
        {
          "id": 237117,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper</span></p>"
        },
        {
          "id": 237118,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        },
        {
          "id": 237119,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoride</span></p>"
        },
        {
          "id": 237120,
          "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with anemia, neutropenia, and depigmentation of hair and nails. Which of the following deficiencies is most likely associated with this presentation? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-130040.jpg\" alt=\"\" width=\"300\" height=\"299\"></span></p>",
      "unique_key": "Q7461086",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Copper</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Copper deficiency can lead to a range of symptoms, including those mentioned in the question:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Anemia:</strong> Copper is essential for iron absorption and red blood cell production. Copper deficiency can result in iron-deficiency anemia or other types of anemia, leading to fatigue and weakness.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neutropenia:</strong> Copper plays a role in immune function. Deficiency can impair the production of white blood cells, including neutrophils, increasing susceptibility to infections.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Depigmentation:</strong> Copper is involved in melanin production, the pigment responsible for hair and nail color. Copper deficiency can cause hair and nails to lose their color.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Iron deficiency:</strong> While iron deficiency also causes anemia, it doesn't typically lead to neutropenia or depigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fluoride deficiency:</strong> Fluoride is primarily associated with dental health. Its deficiency wouldn't cause the symptoms described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Zinc deficiency:</strong> Zinc deficiency can affect skin health and immune function, but it's more likely to present with growth retardation, delayed sexual maturation, and skin lesions rather than the specific combination of symptoms mentioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Copper deficiency can present with a triad of anemia, neutropenia, and depigmentation of hair and nails.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong> Menkes disease, a rare genetic disorder affecting copper transport, is associated with these symptoms and characteristic \"kinky hair.\"</span></p>",
      "correct_choice_id": 237117,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59451/Neet_Pg_Aug_2024_Medicine_Q_36.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59451/Neet_Pg_Aug_2024_Medicine_Q_36.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59452,
      "choices": [
        {
          "id": 237121,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 237122,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        },
        {
          "id": 237123,
          "text": "<p><span style=\"font-size:12.0pt;\">DiGeorge syndrome</span></p>"
        },
        {
          "id": 237124,
          "text": "<p><span style=\"font-size:12.0pt;\">Down syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old patient presents with a history of recurrent sinusitis, bronchiectasis, and chronic cough. He also mentions that he has had several ear infections and episodes of pneumonia over the past few years. On physical examination, you note digital clubbing. A chest X-ray is obtained. What is the most likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-130058.jpg\" alt=\"\" width=\"300\" height=\"337\"></span></p>",
      "unique_key": "Q2123160",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731742,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Kartagener syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome is a rare genetic disorder characterized by the triad of situs inversus (reversal of internal organs), chronic sinusitis, and bronchiectasis. The presence of dextrocardia&nbsp; and the fundic gas bubble on the right side of the abdomen in the chest X-ray strongly suggest situs inversus. The patient's history of recurrent sinusitis, bronchiectasis, and chronic cough further supports the diagnosis of Kartagener syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cystic fibrosis</strong>: Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system. While it can cause recurrent respiratory infections, it is not associated with situs inversus or dextrocardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. DiGeorge syndrome</strong>: DiGeorge syndrome is a genetic disorder that affects the development of several body systems, including the immune system and the heart. It is not associated with situs inversus, bronchiectasis, or chronic sinusitis. &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Down syndrome</strong>: Down syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21. It is not associated with situs inversus, bronchiectasis, or chronic sinusitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome is characterized by the triad of situs inversus, chronic sinusitis, and bronchiectasis.</span></p>",
      "correct_choice_id": 237121,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59452/Neet_Pg_Aug_2024_Medicine_Q_37.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59452/Neet_Pg_Aug_2024_Medicine_Q_37.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59453,
      "choices": [
        {
          "id": 237125,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Digoxin can be used for ventricular rate control.</span></p>"
        },
        {
          "id": 237126,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct oral anticoagulants to be given.</span></p>"
        },
        {
          "id": 237127,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardioversion should be done in hemodynamically unstable patients.</span></p>"
        },
        {
          "id": 237128,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers are given if the patient has decompensated heart failure and intolerant to calcium channel blockers.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old man with a history of hypertension presents with shortness of breath and palpitations. On examination, he has an irregularly irregular pulse with bilateral basal crackles. An ECG shows a ventricular response of 110/min. Which of the following statements is incorrect? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-25-130112.jpg\" alt=\"\" width=\"500\" height=\"278\"></span></p>",
      "unique_key": "Q5475271",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Beta blockers are given if the patient has decompensated heart failure and intolerant to calcium channel blockers</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This statement is incorrect because beta blockers are not recommended in patients with decompensated heart failure. Beta blockers are negative inotropic agents, meaning they decrease the force of the heart's contractions. In a patient with decompensated heart failure, the heart is already struggling to pump blood effectively and further reducing its contractility can worsen the condition. The first-line treatment for rate control in atrial fibrillation with decompensated heart failure is typically calcium channel blockers or digoxin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IV Digoxin can be used for ventricular rate control:</strong> This statement is correct. Digoxin is often used for rate control in atrial fibrillation, especially in patients with heart failure. It works by slowing the conduction of electrical signals through the atrioventricular (AV) node, thereby reducing the heart rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Direct oral anticoagulants to be given:</strong> This statement is generally correct. Direct oral anticoagulants (DOACs) are preferred over warfarin for stroke prevention in patients with non-valvular atrial fibrillation unless there are specific contraindications such as moderate to severe mitral stenosis or a mechanical heart valve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cardioversion should be done in hemodynamically unstable patients:</strong> This statement is correct. Cardioversion, which is the process of restoring a normal heart rhythm using electrical or pharmacological means, is indicated in patients with atrial fibrillation who are hemodynamically unstable. Hemodynamic instability refers to a state where the heart is unable to pump enough blood to meet the body's needs, leading to symptoms such as low blood pressure, shortness of breath, and confusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta blockers should be avoided in patients with decompensated heart failure due to their negative inotropic effects.</span></p>",
      "correct_choice_id": 237128,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59453/Neet_Pg_Aug_2024_Medicine_Q_38.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59453/Neet_Pg_Aug_2024_Medicine_Q_38.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59454,
      "choices": [
        {
          "id": 237129,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased</span></p>"
        },
        {
          "id": 237130,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced</span></p>"
        },
        {
          "id": 237131,
          "text": "<p><span style=\"font-size:12.0pt;\">Equivocal</span></p>"
        },
        {
          "id": 237132,
          "text": "<p><span style=\"font-size:12.0pt;\">Cannot be determined</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presents with complaints of weakness and generalized fatigue. The peripheral smear shows microcytic hypochromic RBCs. Her serum iron is decreased and has increased RDW. Her MCV and MCH were also low, and TIBC was high. What would her serum transferrin saturation be? (NEET PG 2024)</span></p>",
      "unique_key": "Q9565829",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731744,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Reduced</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and lab findings are consistent with iron deficiency anemia. In iron deficiency anemia:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Serum iron</strong> levels are <strong>low</strong> as the body lacks sufficient iron.</span></li><li><span style=\"font-size:12.0pt;\"><strong>TIBC (Total Iron Binding Capacity)</strong> is <strong>high</strong> as the body tries to compensate by increasing its capacity to bind iron.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Transferrin saturation</strong> is the percentage of transferrin (an iron-transport protein) that is saturated with iron. It is calculated as (Serum Iron / TIBC) x 100.</span></li><li><span style=\"font-size:12.0pt;\">Since serum iron is low and TIBC is high, the transferrin saturation will be <strong>reduced</strong>. Typically, in iron deficiency anemia, transferrin saturation is less than 20%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased:</strong> This is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Equivocal:</strong> This is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cannot be determined:</strong> This is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In iron deficiency anemia, transferrin saturation is reduced (typically less than 20%) due to low serum iron and high TIBC.</span></p>",
      "correct_choice_id": 237130,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59454/Neet_Pg_Aug_2024_Medicine_Q_39.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59454/Neet_Pg_Aug_2024_Medicine_Q_39.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59455,
      "choices": [
        {
          "id": 237133,
          "text": "<p><span style=\"font-size:12.0pt;\">Isometric Hand grip</span></p>"
        },
        {
          "id": 237134,
          "text": "<p><span style=\"font-size:12.0pt;\">Valsalva maneuver</span></p>"
        },
        {
          "id": 237135,
          "text": "<p><span style=\"font-size:12.0pt;\">Squatting</span></p>"
        },
        {
          "id": 237136,
          "text": "<p><span style=\"font-size:12.0pt;\">Leaning forward</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young athlete was diagnosed to have HOCM and has a harsh ejection systolic murmur. Which of the following maneuvers would most likely increase the intensity of the murmur? (NEET PG 2024)</span></p>",
      "unique_key": "Q1236628",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Valsalva maneuver</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The intensity of the murmur in hypertrophic obstructive cardiomyopathy (HOCM) is directly related to the degree of left ventricular outflow tract (LVOT) obstruction. The Valsalva maneuver decreases preload (the amount of blood returning to the heart), which in turn, increases the LVOT obstruction and intensifies the murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Isometric Hand grip</strong>: This maneuver increases afterload (the resistance the heart pumps against), which decreases LVOT obstruction and reduces the intensity of the murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Squatting</strong>: Squatting increases preload, leading to a decrease in LVOT obstruction and a reduction in the murmur's intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leaning forward</strong>: This maneuver has no significant effect on the hemodynamics of HOCM and thus does not alter the murmur's intensity. It can, however, accentuate the murmur in aortic stenosis by bringing the aortic valve closer to the chest wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In HOCM, maneuvers that decrease preload (like the Valsalva maneuver) will increase the intensity of the murmur, while those that increase preload or afterload will decrease it.</span></p>",
      "correct_choice_id": 237134,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59455/Neet_Pg_Aug_2024_Medicine_Q_40.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/59455/Neet_Pg_Aug_2024_Medicine_Q_40.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16455,
      "choices": [
        {
          "id": 65780,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propylthiouracil</span></span></p>"
        },
        {
          "id": 65781,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methimazole</span></span></p>"
        },
        {
          "id": 65782,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></p>"
        },
        {
          "id": 65783,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radioactive Iodine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 25-year-old P1L1 woman is planning for her second child. She has been recently diagnosed with Grave&#39;s disease. Which of the following is the antithyroid drug to be used in early gestation? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q2630984",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731746,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Propylthiouracil</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propylthiouracil (PTU) is preferred during the first trimester of pregnancy due to the risk of teratogenic effects from methimazole and carbimazole, such as aplasia cutis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methimazole or carbimazole can be used in the second and third trimesters.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Methimazole and C. Carbimazole:</span></strong><span style=\"font-size:12.0pt\"> Not preferred in the first trimester due to teratogenic risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Radioactive Iodine:</span></strong><span style=\"font-size:12.0pt\"> Absolutely contraindicated in pregnancy &amp; lactation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propylthiouracil is the preferred antithyroid drug during early gestation (first trimester).</span></span></span></p>",
      "correct_choice_id": 65780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11212,
      "choices": [
        {
          "id": 44814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-thalassemia</span></span></span></span></p>"
        },
        {
          "id": 44815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-thalassemia</span></span></span></span></p>"
        },
        {
          "id": 44816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></span></p>"
        },
        {
          "id": 44817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von Willebrand disease type 1 </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy complains of multiple episodes of acute severe pain in his fingers and toes which resolves on its own for the past 1 year. Which of the following conditions is he most likely suffering from? (NEET PG 2018)</span></span></p>",
      "unique_key": "Q6391033",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731747,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Sickle cell anemia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The symptoms described in the question&mdash;acute severe pain episodes in the fingers and toes&mdash;are characteristic of vaso-occlusive crises, which are a hallmark of sickle cell anemia. These episodes are caused by sickle-shaped red blood cells that obstruct blood flow in small blood vessels, leading to ischemic pain. This condition results from a mutation leading to the production of hemoglobin S, which polymerizes under low oxygen conditions, distorting the red blood cells into a sickle shape.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm10.jpg\" style=\"height:357px; width:700px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HbF, &uarr; WBC, LDH is predictive of </span></span><em><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">clinical severity.</span></span></em></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Target Hb &lt; 10g/dL (To minimize risk of Sickling episodes due to high viscosity).</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163858.jpg\" style=\"height:468px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha-thalassemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition involves a deficiency in the production of alpha globin chains but does not typically manifest with acute pain episodes like sickle cell anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Beta-thalassemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Like alpha-thalassemia, this involves a problem with globin chain production (beta chains in this case) and also does not typically present with acute pain episodes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Von Willebrand disease type 1:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a bleeding disorder, not a hemoglobinopathy, characterized by a qualitative or quantitative deficiency of von Willebrand factor, which helps with blood clotting. It would more commonly present with symptoms related to bleeding rather than ischemic pain.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia should be suspected in patients who present with episodic acute pain in the extremities, a symptom commonly resulting from vaso-occlusive crises due to abnormal sickle-shaped red blood cells blocking blood flow.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21 /Hemoglobinopathies/Chapter 98</span></span></strong></p>",
      "correct_choice_id": 44816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84303,
      "choices": [
        {
          "id": 335788,
          "text": "<p><span style=\"font-size:12.0pt;\">Portal Hypertension</span></p>"
        },
        {
          "id": 335789,
          "text": "<p><span style=\"font-size:12.0pt;\">Isolated splenic vein thrombosis</span></p>"
        },
        {
          "id": 335790,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug-induced gastritis</span></p>"
        },
        {
          "id": 335791,
          "text": "<p><span style=\"font-size:12.0pt;\">Mallory-Weiss Tear</span></p>"
        }
      ],
      "text": "<p>A man presents with a history of hematemesis involving approximately 500 ml of blood. On examination, his spleen is palpable 5 cm below the left costal margin. What is the most likely diagnosis? (NEET PG 2016)</p>",
      "unique_key": "Q2486917",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. A) Portal Hypertension</strong></p><p>&nbsp;</p><p>The patient presents with hematemesis (vomiting blood) and splenomegaly (enlarged spleen palpable 5 cm below the costal margin). These two findings strongly suggest portal hypertension as the most likely diagnosis. Portal hypertension is defined as an elevation of hepatic venous pressure gradient &gt;5 mmHg and is <strong>directly responsible for variceal hemorrhage</strong>, a major complication that can present with hematemesis. The combination of splenomegaly and upper GI bleeding in the form of hematemesis is characteristic of portal hypertension.</p><p>&nbsp;</p><p><strong>Other Options:&nbsp;</strong></p><p>&nbsp;</p><p><strong>Option B. Isolated splenic vein thrombosis</strong>: While this can cause localized portal hypertension with splenomegaly, it typically causes gastric rather than esophageal varices. The pattern of bleeding would be different, and it's much less common than generalized portal hypertension.</p><p>&nbsp;</p><p><strong>Option C. Drug-induced gastritis</strong>: This can cause hematemesis but doesn't explain the significant splenomegaly. Gastritis alone would not cause spleen enlargement of this magnitude (5 cm below costal margin).</p><p>&nbsp;</p><p><strong>Option D. Mallory-Weiss tear</strong>: This is a mucosal laceration at the gastroesophageal junction typically occurring after forceful vomiting. While it can cause hematemesis, it would not explain the splenomegaly, which is a key finding in this case.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The combination of significant hematemesis and splenomegaly strongly suggests portal hypertension with variceal bleeding, which is one of the major life-threatening complications of cirrhosis requiring prompt management.</p>",
      "correct_choice_id": 335788,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52313,
      "choices": [
        {
          "id": 208749,
          "text": "<p><span style=\"font-size:12.0pt;\">Delirium Tremens</span></p>"
        },
        {
          "id": 208750,
          "text": "<p><span style=\"font-size:12.0pt;\">Wernickeâ€™s Encephalopathy</span></p>"
        },
        {
          "id": 208751,
          "text": "<p><span style=\"font-size:12.0pt;\">Korsakoff Psychosis</span></p>"
        },
        {
          "id": 208752,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol Withdrawal Seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient stopped alcohol 3 days ago, presented with irritability, altered sensorium, and visual hallucinations. What is the likely diagnosis?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q3220222",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731749,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Delirium Tremens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delirium Tremens (DT) is a severe form of alcohol withdrawal that typically occurs 48-72 hours after the last drink. It is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Autonomic instability (e.g., tachycardia, hypertension, hyperthermia)</span></li><li><span style=\"font-size:12.0pt;\">Severe agitation and irritability</span></li><li><span style=\"font-size:12.0pt;\">Altered sensorium (e.g., confusion, delirium)</span></li><li><span style=\"font-size:12.0pt;\">Visual and auditory hallucinations</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DT is a medical emergency with high morbidity and mortality if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>treatment of choice is benzodiazepines</strong>, which help to control agitation and prevent complications such as seizures. Long-acting benzodiazepines like diazepam are preferred unless there is liver dysfunction, in which case shorter-acting agents like lorazepam or oxazepam are used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Special Considerations for Liver Impairment</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cirrhosis or Severe Liver Failure</strong>: In patients with compromised liver function, the metabolism of drugs, particularly those processed by the liver, can be significantly impaired.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Short-Acting Drugs</strong>: Lorazepam is recommended as it is less reliant on hepatic oxidation and more on glucuronidation, which is relatively preserved in liver disease.</span></li><li><span style=\"font-size:12.0pt;\">Oxazepam is also suggested as it undergoes direct conjugation in the liver without the need for extensive metabolism, making it safer for patients with severe liver impairment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Wernickeâ€™s Encephalopathy:</strong> Wernickeâ€™s Encephalopathy is caused by thiamine deficiency and presents with a triad of ophthalmoplegia, ataxia, and confusion. It does not typically present with hallucinations or irritability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Korsakoff Psychosis:</strong> Korsakoff Psychosis is a chronic condition resulting from untreated Wernickeâ€™s Encephalopathy, characterized by severe memory impairment/ amnesia and confabulation. It does not present acutely and lacks the autonomic instability seen in DT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alcohol Withdrawal Seizures:</strong> Alcohol withdrawal seizures typically occur within 6-48 hours after the last drink and present as generalized tonic-clonic seizures (GTCS). They do not present with the prolonged altered sensorium or hallucinations characteristic of DT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delirium Tremens is a severe alcohol withdrawal syndrome occurring 48-72 hours after cessation of alcohol intake, characterized by autonomic instability, severe agitation, altered sensorium, and hallucinations. It requires immediate treatment with benzodiazepines to manage symptoms and prevent complications.</span></p>",
      "correct_choice_id": 208749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11358,
      "choices": [
        {
          "id": 45398,
          "text": "<p>Cabergoline</p>"
        },
        {
          "id": 45399,
          "text": "<p>Bromocriptine</p>"
        },
        {
          "id": 45400,
          "text": "<p>Octreotide</p>"
        },
        {
          "id": 45401,
          "text": "<p>Pegvisomant</p>"
        }
      ],
      "text": "<p>A female patient with infertility presents with galactorrhea. Evaluation reveals a 7mm prolactinoma. She is worried about her conception chances. What is the appropriate drug in this situation? (NEET PG 2022)</p>",
      "unique_key": "Q9105413",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731750,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B. Bromocriptine</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The choice of dopamine agonist therapy for hyperprolactinemia in patients desiring fertility remains somewhat controversial. Advanced textbooks such as \"Speroff's Clinical Gynecologic Endocrinology and Infertility\" clearly highlight that cabergoline has greater potency, fewer side effects, better tolerability, and convenient dosing compared to bromocriptine, leading to its general preference for prolactinoma treatment.</p><p>&nbsp;</p><p>However, Harrison's Principles of Internal Medicine (21st Edition) explicitly mentions:</p><p>&nbsp;</p><p>â€œBecause <strong>cabergoline</strong> is long-acting with a high Dâ‚‚-receptor affinity, it is not recommended for use in women when fertility is desired.â€</p><p>&nbsp;</p><p>Considering the context of Indian postgraduate entrance examinations, it is advisable to adhere to Harrison's recommendations. Therefore, although cabergoline is generally considered superior, <strong>bromocriptine</strong> is the safer and recommended answer for this specific examination scenario.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A</strong>. Cabergoline: Although generally preferred for routine prolactinoma management, it is explicitly not recommended during conception planning as per Harrisonâ€™s.</p><p>&nbsp;</p><p><strong>Option C</strong>. Octreotide: A somatostatin analog indicated exclusively for GH-secreting tumors, not prolactinoma.</p><p>&nbsp;</p><p><strong>Option D</strong>. Pegvisomant: A GH receptor antagonist used specifically in acromegaly, with no role in prolactinoma or fertility management.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>For Indian PG entrance examinations, bromocriptine remains the recommended first-line treatment in women with microprolactinoma who desire fertility, despite cabergolineâ€™s clinical advantages, based on guidelines explicitly mentioned in Harrisonâ€™s Principles of Internal Medicine.</p>",
      "correct_choice_id": 45399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Controversial",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11259,
      "choices": [
        {
          "id": 45002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop oral methotrexate and start parenteral methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add sulfasalazine and hydroxychloroquine</span></span></span></span></p>"
        },
        {
          "id": 45004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue corticosteroids and methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45005,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start only anti-TNF alpha agents</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with rheumatoid arthritis is being treated with methotrexate and low-dose corticosteroids for the past 4 months. However, the disease is still progressing. What would be your recommendation for the further management of this patient? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q9017136",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731751,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Add sulfasalazine and hydroxychloroquine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adding sulfasalazine and hydroxychloroquine to the treatment regimen for a patient with rheumatoid arthritis who is not responding adequately to methotrexate and low-dose corticosteroids is a sound strategy. This approach follows the principle of combining different disease-modifying antirheumatic drugs (DMARDs) to achieve better disease control. Both sulfasalazine and hydroxychloroquine are DMARDs that work by different mechanisms to reduce inflammation and slow disease progression in rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop oral methotrexate and start parenteral methotrexate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While switching to parenteral administration can increase the effectiveness of methotrexate for some patients, it might not be sufficient alone if the disease is still progressing.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Continue corticosteroids and methotrexate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continuing the same treatment without modification is not advisable if the disease is actively progressing, as this indicates that the current regimen is insufficient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start only anti-TNF alpha agents:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While anti-TNF agents are effective for many patients, they are typically used after trying combination DMARD therapy, especially in cases not severe enough to warrant immediate biologic therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When a patient with rheumatoid arthritis does not respond adequately to initial therapy with methotrexate and corticosteroids, the addition of other DMARDs such as sulfasalazine and hydroxychloroquine can be beneficial.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start 10mg/week &rarr; max 25mg/week along with Folic acid twice/week</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Check ocular fundus before HCQ initiation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leflunomide, sulfasalazine other group of drugs.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulfasalazine is safe in pregnancy !!</span></span></em></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptomatic relief with NSAID and short course corticosteroids.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatoid arthritis/ Chap 358</span></span></strong></p>",
      "correct_choice_id": 45003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84348,
      "choices": [
        {
          "id": 335964,
          "text": "<p>Hepatitis</p>"
        },
        {
          "id": 335965,
          "text": "<p>Hemolytic jaundice</p>"
        },
        {
          "id": 335966,
          "text": "<p>Obstructive jaundice</p>"
        },
        {
          "id": 335967,
          "text": "<p>Gilbertâ€™s syndrome</p>"
        }
      ],
      "text": "<p>A patient presents with elevated bilirubin levels. Urine urobilinogen is absent, but urine bilirubin is present. What is the most likely diagnosis?&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q8965731",
      "question_audio": null,
      "question_video": null,
      "map_id": 35731752,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Obstructive jaundice</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>The pattern of laboratory findings with <strong>elevated bilirubin levels, presence of bilirubin in urine, and absence of urobilinogen in urine</strong> is characteristic of obstructive (cholestatic) jaundice. In obstructive jaundice, conjugated bilirubin cannot be excreted into the intestine due to biliary obstruction. This conjugated hyperbilirubinemia results in spillage of water-soluble conjugated bilirubin into urine (bilirubinuria). Since bilirubin cannot reach the intestine, there is no formation of urobilinogen by intestinal bacteria, resulting in absent urinary urobilinogen.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Hepatitis</strong>: While hepatitis can cause elevated bilirubin, it typically has a mixed pattern with both direct and indirect bilirubin elevation. In hepatitis, urobilinogen would be present or elevated in urine due to continued, albeit reduced, flow of bilirubin to the intestines where it is converted to urobilinogen.</p><p>&nbsp;</p><p><strong>Option B. Hemolytic jaundice</strong>: In hemolytic jaundice, there is unconjugated (indirect) hyperbilirubinemia due to excessive destruction of red blood cells. Since unconjugated bilirubin is not water-soluble, it cannot appear in urine. Urobilinogen would be increased, not absent, due to increased bilirubin load reaching the intestines.</p><p>&nbsp;</p><p><strong>Option D. Gilbert's syndrome</strong>: This is characterized by mild unconjugated hyperbilirubinemia. As with hemolytic jaundice, unconjugated bilirubin does not appear in urine. Additionally, urobilinogen would be normal or slightly increased in Gilbert's syndrome, not absent.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The key diagnostic pattern for obstructive jaundice is the presence of conjugated hyperbilirubinemia leading to bilirubinuria with absent urinary urobilinogen due to blockage of bilirubin flow into the intestine.</p>",
      "correct_choice_id": 335966,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}